Literature DB >> 32705086

Ovarian Stimulation Increases the Risk of Fetal Cardiac Defects of Pups Exposed to Severe Maternal Hyperglycemia.

Rolanda Lister1, Etoi Garrison1, Francine Hughes2, Scott Baldwin3, Bin Zhou4.   

Abstract

OBJECTIVES: To study the incidence of congenital heart defects (CHD) in offspring born to hyperglycemic mothers with and without ovarian stimulation.
DESIGN: Reproductive biology.
SETTING: Mouse model. PATIENTS: N/A. INTERVENTION: Hyperglycemia was induced in CD-1 wild type female mice using a single intraperitoneal dose of 150 mg/kg of streptozotocin. Stimulated dams (SD); (n=3) were injected with pregnant mare serum and human chorionic gonadotropin 48 hours apart. Non-stimulated dams (NSD); (n=4) were not injected. Both groups were mated with normal male CD-1 mice for timed pregnancies. Fetal hearts were extracted on embryonic day 16.5 and histological analyses was performed. Student's t-tests were employed to compare the incidence of cardiac defects in the SD and NSD groups. P ≤ 0.05 was significant. MAIN UUTCOME MEASURE: The incidence of CHD in progeny of diabetic dams with and without ovarian hyperstimulation. RESULTS &
CONCLUSIONS: The average litter size was higher in SD compared to NSD. The average blood glucose for the SD and NSD was similar. Overall, the incidence of cardiac malformations did not differ between the two groups. However, in severe maternal hyperglycemia (>400 mg/dL), there was a higher incidence of fetal cardiac malformations in the pups born to SD vs NSD.

Entities:  

Keywords:  Congenital heart defects; Human chorionic gonadotropin; Hyperglycemia; Ovarian stimulation; Pregnant mare serum

Year:  2019        PMID: 32705086      PMCID: PMC7377632          DOI: 10.33425/2639-9342.1074

Source DB:  PubMed          Journal:  Gynecol Reprod Health        ISSN: 2639-9342


  20 in total

1.  Evaluation of fetal echocardiography as a routine antenatal screening tool for detection of congenital heart disease.

Authors:  Krishnananda Nayak; Naveen Chandra G S; Ranjan Shetty; Pratap Kumar Narayan
Journal:  Cardiovasc Diagn Ther       Date:  2016-02

2.  Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005.

Authors:  Jean M Lawrence; Richard Contreras; Wansu Chen; David A Sacks
Journal:  Diabetes Care       Date:  2008-01-25       Impact factor: 19.112

Review 3.  Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis.

Authors:  Rinat Gabbay-Benziv; E Albert Reece; Fang Wang; Peixin Yang
Journal:  World J Diabetes       Date:  2015-04-15

Review 4.  Polycystic ovary syndrome.

Authors:  S Franks
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

5.  The impact of congenital malformations on public health.

Authors:  L Sever; M C Lynberg; L D Edmonds
Journal:  Teratology       Date:  1993-12

6.  Congenital defects in assisted reproductive technology pregnancies.

Authors:  P Sala; S Ferrero; D Buffi; D Pastorino; S Bertoldi; L Vaccari; G Bentivoglio; P L Venturini; P De Biasio
Journal:  Minerva Ginecol       Date:  2011-06

Review 7.  Experimental diabetes induced by alloxan and streptozotocin: The current state of the art.

Authors:  Miroslav Radenković; Marko Stojanović; Milica Prostran
Journal:  J Pharmacol Toxicol Methods       Date:  2015-11-17       Impact factor: 1.950

Review 8.  The incidence of congenital heart disease.

Authors:  Julien I E Hoffman; Samuel Kaplan
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

9.  Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection.

Authors:  William M Buckett; Ri-Cheng Chian; Hananel Holzer; Nicola Dean; Robert Usher; Seang Lin Tan
Journal:  Obstet Gynecol       Date:  2007-10       Impact factor: 7.661

10.  Assisted Reproductive Technology Surveillance - United States, 2014.

Authors:  Saswati Sunderam; Dmitry M Kissin; Sara B Crawford; Suzanne G Folger; Denise J Jamieson; Lee Warner; Wanda D Barfield
Journal:  MMWR Surveill Summ       Date:  2017-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.